Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

ANGO

AngioDynamics (ANGO)

AngioDynamics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANGO
DataHoraFonteTítuloCódigoCompanhia
23/10/202409:00Business WireAngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® SystemNASDAQ:ANGOAngioDynamics Inc
21/10/202409:00Business WireAngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and LiverNASDAQ:ANGOAngioDynamics Inc
10/10/202416:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/10/202418:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGOAngioDynamics Inc
03/10/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGOAngioDynamics Inc
03/10/202407:30Business WireAngioDynamics Reports Fiscal Year 2025 First Quarter Financial ResultsNASDAQ:ANGOAngioDynamics Inc
26/09/202415:59Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ANGOAngioDynamics Inc
26/09/202415:57Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ANGOAngioDynamics Inc
19/09/202417:40Business WireAngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional OutcomesNASDAQ:ANGOAngioDynamics Inc
19/09/202409:00Business WireAngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024NASDAQ:ANGOAngioDynamics Inc
03/09/202409:30Business WireAngioDynamics Announces CE Mark Approval in Europe for the Auryon SystemNASDAQ:ANGOAngioDynamics Inc
29/07/202417:15Business WireAngioDynamics to Participate in Upcoming Investor ConferencesNASDAQ:ANGOAngioDynamics Inc
25/07/202417:13Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANGOAngioDynamics Inc
16/07/202407:30Business WireAngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial ResultsNASDAQ:ANGOAngioDynamics Inc
16/07/202407:12IH Market NewsUS Index Futures Steady, Oil Prices Dip Amid China Slowdown, Key Earnings Reports AheadNASDAQ:ANGOAngioDynamics Inc
08/07/202417:30Business WireAngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024NASDAQ:ANGOAngioDynamics Inc
21/05/202418:30Business WireAngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ SystemNASDAQ:ANGOAngioDynamics Inc
06/05/202417:45Business WireAngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific SessionsNASDAQ:ANGOAngioDynamics Inc
04/04/202408:31IH Market NewsUS Index Futures Rise, Oil Dips SlightlyNASDAQ:ANGOAngioDynamics Inc
04/04/202408:00Business WireAngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset DivestitureNASDAQ:ANGOAngioDynamics Inc
04/04/202407:45Business WireAngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PENASDAQ:ANGOAngioDynamics Inc
01/04/202418:26Business WireAngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.NASDAQ:ANGOAngioDynamics Inc
19/03/202417:01Business WireAngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024NASDAQ:ANGOAngioDynamics Inc
06/03/202418:01Business WireAngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services ConferenceNASDAQ:ANGOAngioDynamics Inc
15/02/202418:05Business WireAngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 MillionNASDAQ:ANGOAngioDynamics Inc
23/01/202418:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANGOAngioDynamics Inc
23/01/202410:00Business WireAngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial DiseaseNASDAQ:ANGOAngioDynamics Inc
05/01/202409:00Business WireAngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 GuidanceNASDAQ:ANGOAngioDynamics Inc
21/12/202318:01Business WireAngioDynamics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:ANGOAngioDynamics Inc
07/12/202318:01Business WireAngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024NASDAQ:ANGOAngioDynamics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANGO